Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
grade F 1.0024 18.07% 0.15
ACHV closed up 1.07 percent on Tuesday, November 19, 2019, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Up
See historical ACHV trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 18.07%
NR7 Range Contraction 18.07%
NR7-2 Range Contraction 18.07%
Wide Bands Range Expansion 18.07%
Oversold Stochastic Weakness 18.07%
Narrow Range Bar Range Contraction 19.33%
NR7 Range Contraction 19.33%
NR7-2 Range Contraction 19.33%
New 52 Week Low Weakness 19.33%
Wide Bands Range Expansion 19.33%

Older signals for ACHV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
ACHV Chart by TradingView
Basic chart:
Profile
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Biopharmaceutical Cancer Cancers Prostate Cancer Breast Cancer Non Small Cell Lung Cancer Oncolytics Biotech
Is ACHV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 12 The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
Nov 11 ACHV: After Capital Raise Ready for Phase III
Nov 11 Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q3 2019 Results - Earnings Call Transcript
Nov 6 Achieve down 14% on planned equity offering
Nov 6 Earnings dominate premarket losers
Nov 6 Achieve Life Sciences EPS misses by $0.15
Nov 6 Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
Oct 31 Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019
Oct 24 Achieve Life Sciences to launch late-stage development of cytisinicline in 2020
Oct 24 What Type Of Shareholder Owns Achieve Life Sciences, Inc.'s (NASDAQ:ACHV)?
See more ACHV news...
Indicators
Indicator Value
52 Week High 4.63
52 Week Low 0.83
Average Volume 116,566
200-Day Moving Average 2.4307
50-Day Moving Average 1.5476
20-Day Moving Average 1.1291
10-Day Moving Average 0.9002
Average True Range 0.0984
ADX 54.49
+DI 7.1211
-DI 35.3513
Chandelier Exit (Long, 3 ATRs ) 1.2248
Chandelier Exit (Short, 3 ATRs ) 1.1252
Upper Bollinger Band 1.6126
Lower Bollinger Band 0.6456
Percent B (%b) 0.21
BandWidth 85.643433
MACD Line -0.2072
MACD Signal Line -0.1964
MACD Histogram -0.0108
Fundamentals Value
Market Cap 9.29 Million
Num Shares 10.9 Million
EPS -56.38
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.90
Resistance 3 (R3) 0.90 0.89 0.89
Resistance 2 (R2) 0.89 0.88 0.89 0.89
Resistance 1 (R1) 0.87 0.87 0.88 0.87 0.89
Pivot Point 0.85 0.85 0.86 0.85 0.85
Support 1 (S1) 0.83 0.84 0.84 0.83 0.81
Support 2 (S2) 0.82 0.83 0.82 0.81
Support 3 (S3) 0.80 0.82 0.81
Support 4 (S4) 0.80